These treatments are FDA-indicated for: Adults with a BMI of 30 or higher
Patients who maintain or build muscle during GLP-1 treatment experience less metabolic slowdown and better weight maintenance after stopping
In this episode of the Huberman Lab, Huberman delves into the science behind habit formation and change, examining how neuroplasticity enables our brains to develop and strengthen habitual behaviors
These mechanisms of action are primarily achieved by promoting the acetylation and nuclear translocation of NRF2, which in turn enhances the function of NRF2 in antioxidant and anti-inflammatory responses [67]
In a subsequent functional magnetic resonance imaging (fMRI) study, this observation was replicated and both l-theanine and caffeine were found to decrease task-related reactivity of DMN, possibly decreasing mind wandering 33
Nevertheless, no further investigation was performed with regard to clinical efficacy due to safety concerns